Mesoblast Limited (ASX:MSB)

Mesoblast Revenue

Mesoblast had revenue of $51.34M USD in the half year ending December 31, 2025, with 1,415.41% growth. This brings the company's revenue in the last twelve months to $65.38M, up 1,053.16% year-over-year. In the fiscal year ending June 30, 2025, Mesoblast had annual revenue of $17.20M with 191.39% growth.

• Revenue (ttm): $65.38M
• Revenue Growth: +1,053.16%
• P/S Ratio: 26.14
• Revenue / Employee: $807.21K
• Employees: 81
• Market Cap: 2.56B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	17.20M	11.30M	191.39%
Jun 30, 2024	5.90M	-1.60M	-21.32%
Jun 30, 2023	7.50M	-2.71M	-26.54%
Jun 30, 2022	10.21M	2.78M	37.36%
Jun 30, 2021	7.43M	-24.72M	-76.88%
Jun 30, 2020	32.16M	15.43M	92.30%
Jun 30, 2019	16.72M	-619.00K	-3.57%
Jun 30, 2018	17.34M	14.93M	618.95%
Jun 30, 2017	2.41M	-40.14M	-94.33%
Jun 30, 2016	42.55M	9.79M	29.88%
Jun 30, 2015	32.76M	9.37M	40.05%
Jun 30, 2014	23.39M	-8.33M	-26.26%
Jun 30, 2013	31.72M	-7.41M	-18.93%
Jun 30, 2012	39.12M	-90.48M	-69.81%
Jun 30, 2011	129.60M	128.97M	20,433.19%
Jun 30, 2010	631.18K	-89.51K	-12.42%
Jun 30, 2009	720.69K	-152.06K	-17.42%
Jun 30, 2008	872.75K	-553.16K	-38.79%
Jun 30, 2007	1.43M	-669.68K	-31.96%
Jun 30, 2006	2.10M	1.71M	447.74%
Jun 30, 2005	382.59K	-	-